Company intelligence / Profile preview

Highline Sciences

San Francisco, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Highline Sciences is a specialized clinical research organization (CRO) that provides full-service clinical trial management with a primary focus on oncology. The company offers expertise in study design, site identification, clinical monitoring, and data management for biotechnology and pharmaceutical clients. Founded in 2019 and headquartered in San Francisco, Highline Sciences was acquired by Vial in 2022 to integrate its oncology-specific operational excellence with Vial's technology-enabled CRO platform. The firm is recognized for its high-touch service model and ability to execute complex early-to-late-phase clinical programs.

Therapeutic areas: Oncology
Industry: Contract Research Organization

Beyond the preview

Go deeper on Highline Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Highline Sciences.

Explore the full profile